Patient Square Capital
Crossover fundMenlo Park Β· Growth
Investment thesis
Patient Square Capital focuses exclusively on the health care industry, partnering with premier management teams whose products, services, and technologies improve health. It invests broadly across subsectors including development-stage therapeutics, commercial-stage pharmaceuticals, medical devices, diagnostics, life science tools, health care providers, and tech-enabled services. The firm draws on deep sector knowledge, an extensive industry network, and experience investing in both private and public companies to identify and create value. It emphasizes a partnership model built on trusted relationships and alignment, and applies operational capabilities to support and scale companies throughout their lifecycle, helping them transform in a dynamic industry.
Source: firm website, verified Aug 11, 2026.
What they invest in
from 2 of 18 portfolio companiesBiotech Γ2
HQs:United StatesΓ1
Investments Β· 18 tracked
founders shown can be your intro pathBiopharmaceutical gene therapy company developing gene therapies intended to be accessible broadly rather than to a limited few.
BiotechMorrisville, US
Ilan Oren(Director)Shankar Ramaswamy(Executive Officer, Director)Michele Stone(Executive Officer)Katherine Eade(Executive Officer)Britt Petty(Executive Officer)Daniel Chen(Executive Officer)
Syneos Health is a contract research and commercialization services company that supports biopharmaceutical companies in drug development, regulatory affairs, and market launch across therapeutic areas.
Biotech
Frequently asked questions
- What stage does Patient Square Capital invest at?
- Patient Square Capital invests at the Growth stage.
- What sectors does Patient Square Capital focus on?
- Patient Square Capital focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices, Sector Agnostic.
- Where is Patient Square Capital located?
- Patient Square Capital is headquartered in Menlo Park, US.
Images
Similar investors
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.
Blackstone Life Sciences (BXLS) is Blackstone's life sciences investment arm that designs, funds and executes clinical trials to advance late-stage pharmaceutical, biotech and medical technology products to market.
Lumira Ventures is a North American life sciences venture capital firm that partners with mission-driven entrepreneurs to build companies developing and commercializing healthcare products for patients.